Evidence that proximal multiple mutations in Big Blue® transgenic mice are dependent events

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 452, Issue 2, 2000, Pages 219-229

  Buettner, Victoria L ^a   Hill, Kathleen A ^a   Scaringe, William A ^a   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

lacI transgene; Mutator phenotype; Spontaneous mutations; Tumorigenesis

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMAL; MICE; MICE, TRANSGENIC; MUTATION; NEOPLASMS, EXPERIMENTAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034683726     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00090-7     Document Type: Article

References (28)

1. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
2. L. Loeb, Cancer cells exhibit a mutator phenotype, Cancer Res. (1998) 25-55.
3. Sommer S. Recent human germ-line mutation: inferences from patients with hemophilia B. Trends Genet. 11:1995;141-147.
4. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
5. Loeb L.A., Christians F.C. Multiple mutations in human cancers. Mutat. Res. 350:1996;279-286.
6. Bebenek K., Roberts J.D., Kunkel T.A. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J. Biol. Chem. 267:1992;3589-3596.
7. Seidman M.M., Bredberg A., Seetharam S., Kraemer K.H. Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity. Proc. Natl. Acad. Sci. U. S. A. 84:1987;4944-4948.
8. Beard W.A., Osheroff W.P., Prasad R., Sawaya M.R., Jaju M., Wood T.G., Kraut J., Kunkel T.A., Wilson S.H. Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase b. J. Biol. Chem. 271:1996;12141-12144.
9. Baross-Francis A., Andrew S.E., Penney J.E., Jirik F.R. Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8739-8743.
10. Andrew S.E., Reitmair A.H., Fox J., Hsiao L., Francis A., McKinnon M., Mak T.W., Jirik F.R. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice. Oncogene. 15:1997;123-129.
11. Narayanan L., Fritzell J.A., Baker S.M., Liskay R.M., Glazer P.M. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3122-3127.
12. Strauss B.S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis. 18:1997;1445-1452.
13. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 88:1991;7958-7962.
14. Hill K.A., Buettner V.L., Glickman B.W., Sommer S.S. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat. Res. 436:1999;11-19.
15. Buettner V.L., Hill K.A., Nishino H., Schaid D.J., Frisk C.S., Sommer S.S. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue transgenic mice. Oncogene. 13:1996;2407-2413.
16. Sands A.T., Suraokar M.B., Sanchez A., Marth J.E., Donehower L.A., Bradley A. p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8517-8521.
17. Nishino H., Buettner V.L., Haavik J., Schaid D.J., Sommer S.S. Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender, and tissue type. Environ. Mol. Mutagen. 28:1996;299-312.
18. Buettner V.L., Nishino H., Haavik J., Knöll A., Hill K.A., Sommer S.S. Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: a test of the 'guardian of the genome' hypothesis in the Big Blue transgenic mouse mutation detection system. Mutat. Res. 379:1997;13-20.
19. Nishino H., Knöll A., Buettner V.L., Frisk C.S., Maruta Y., Haavik J., Sommer S.S. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene. 11:1995;263-270.
20. Buettner V.L., Nishino H., Sommer S.S. Large deletions detected with Big Blue transgenic mouse mutagenesis assay. Mutat. Res. 361:1996;187-189.
21. Farabaugh P.J. Sequence of the lacI gene. Nature. 274:1978;765-775.
22. Harwood J., Tachibana A., Meuth M. Multiple dispersed spontaneous mutations: a novel pathway of mutation in a malignant human cell line. Mol. Cell. Biol. 11:1991;3163-3170.
23. Lane B., Mimms S. The genetic consequences of DNA precursor pool imbalance: sequence analysis of mutations induced by excess thymidine at the hamster aprt locus. Mutat. Res. 214:1989;201-206.
24. Phear G., Nalbantoglu J., Meuth M. Next-nucleotide effects in mutations driven by DNA precursor pool imbalances at the aprt locus of Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U. S. A. 84:1987;4450-4454.
25. Buettner V.L., Hill K.A., Halangoda A., Sommer S.S. Tandem-based mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age. Environ. Mol. Mutagen. 33:1999;320-324.
26. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24:1996;141-146.
27. DeVries E.M.G., Ricke D.O., DeVries T.N., Hartmann A., Blaszyk H., Liao D., Soussi T., Kovach J.S., Sommer S.S. Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses. Hum. Mutat. 7:1996;202-213.
28. Hartmann A., Blaszyk H., Saitoh S., Tsushima K., Tamura Y., Cunningham J.M., McGovern R.M., Schroeder J.J., Sommer S.S., Kovach J.S. High frequency of p53 mutations in primary breast cancers in Japanese women, a low-incidence population. Br. J. Cancer. 73:1996;896-901.